<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>RGE-GCN: Recursive Gene Elimination with Graph Convolutional Networks for RNA-seq based Early Cancer Detection - Health AI Hub</title>
    <meta name="description" content="RGE-GCN is a novel framework that integrates Graph Convolutional Networks (GCNs) with recursive gene elimination for highly accurate and interpretable early can">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>RGE-GCN: Recursive Gene Elimination with Graph Convolutional Networks for RNA-seq based Early Cancer Detection</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.04333v1" target="_blank">2512.04333v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-03
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Shreyas Shende, Varsha Narayanan, Vishal Fenn, Yiran Huang, Dincer Goksuluk, Gaurav Choudhary, Melih Agraz, Mengjia Xu
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.LG, cs.AI
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.04333v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.04333v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">RGE-GCN is a novel framework that integrates Graph Convolutional Networks (GCNs) with recursive gene elimination for highly accurate and interpretable early cancer detection using RNA-seq data. It identifies compact sets of predictive biomarkers by building gene expression graphs and iteratively removing less relevant genes, outperforming traditional differential expression methods. The selected genes align with well-known cancer pathways, suggesting its promise as a generalizable tool for biomarker discovery.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is crucial for improving cancer survival rates by enhancing the early detection of cancer. By providing a robust and interpretable method to identify reliable gene biomarkers from complex RNA-seq data, it can lead to more precise and earlier diagnoses, facilitating timely interventions and potentially personalized treatment strategies.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>AI, specifically Graph Convolutional Networks (GCNs), is applied to high-dimensional RNA-seq gene expression data to develop a framework for early cancer detection. It acts as a diagnostic tool by classifying cancer vs. normal samples and as a discovery tool by identifying interpretable and predictive gene biomarkers for various types of cancer (lung, kidney, cervical), potentially leading to improved screening and personalized treatment strategies.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Introduces RGE-GCN (Recursive Gene Elimination with Graph Convolutional Networks), a framework combining feature selection and classification for high-dimensional RNA-seq data in a single pipeline.</li>
                    
                    <li>The method constructs a gene expression graph, employs a Graph Convolutional Network (GCN) for binary classification (cancer vs. normal), and uses Integrated Gradients to assess gene importance.</li>
                    
                    <li>Recursively eliminates less relevant genes, converging on a compact set of highly predictive and biologically interpretable biomarkers.</li>
                    
                    <li>Evaluated on synthetic data and real-world RNA-seq cohorts for lung, kidney, and cervical cancers.</li>
                    
                    <li>Consistently achieved superior accuracy and F1-scores compared to standard differential expression tools like DESeq2, edgeR, and limma-voom across all tested datasets.</li>
                    
                    <li>Selected genes were significantly enriched in well-known cancer pathways, including PI3K-AKT, MAPK, SUMOylation, and immune regulation, validating their biological relevance.</li>
                    
                    <li>RGE-GCN demonstrates potential as a generalizable approach for RNA-seq based early cancer detection and biomarker discovery.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>RGE-GCN builds a graph representing gene relationships from RNA-seq expression profiles. This graph is then processed by a Graph Convolutional Network (GCN) to classify samples as cancer or normal. To identify the most informative genes, Integrated Gradients are applied to the GCN outputs. Subsequently, a recursive gene elimination process is employed, where genes deemed less relevant by the Integrated Gradients are iteratively removed, allowing the model to converge on a compact, optimal set of predictive biomarkers.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The RGE-GCN framework consistently demonstrated superior performance, achieving higher accuracy and F1-scores than established differential expression tools (DESeq2, edgeR, limma-voom) across synthetic data and real RNA-seq cohorts of lung, kidney, and cervical cancers. Crucially, the genes identified as key biomarkers by RGE-GCN were found to be significantly associated with well-known cancer-related pathways, including PI3K-AKT, MAPK, SUMOylation, and immune regulation, enhancing the biological interpretability and validity of the results.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>RGE-GCN offers a promising clinical impact by enabling more accurate and earlier detection of various cancers through RNA-seq data. By identifying a compact and biologically interpretable set of biomarkers, it could streamline diagnostic processes, inform risk assessment, and support the development of targeted therapies. Its generalizable nature suggests it could be broadly applicable across different cancer types, potentially leading to improved patient management and survival outcomes in oncology.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations of the RGE-GCN framework.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>While not explicitly stated in the abstract, the results suggest RGE-GCN is a generalizable approach. Implied future directions could include validation on larger and more diverse patient cohorts, exploration of its utility in multi-omics integration, or investigating its potential for predicting cancer prognosis or therapeutic response.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Oncology</span>
                    
                    <span class="tag">Cancer Diagnostics</span>
                    
                    <span class="tag">Precision Medicine</span>
                    
                    <span class="tag">Lung Cancer</span>
                    
                    <span class="tag">Kidney Cancer</span>
                    
                    <span class="tag">Cervical Cancer</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">RNA-seq</span>
                    
                    <span class="tag tag-keyword">Early Cancer Detection</span>
                    
                    <span class="tag tag-keyword">Biomarker Discovery</span>
                    
                    <span class="tag tag-keyword">Graph Convolutional Networks</span>
                    
                    <span class="tag tag-keyword">Feature Selection</span>
                    
                    <span class="tag tag-keyword">Machine Learning</span>
                    
                    <span class="tag tag-keyword">Gene Expression</span>
                    
                    <span class="tag tag-keyword">Oncology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Early detection of cancer plays a key role in improving survival rates, but identifying reliable biomarkers from RNA-seq data is still a major challenge. The data are high-dimensional, and conventional statistical methods often fail to capture the complex relationships between genes. In this study, we introduce RGE-GCN (Recursive Gene Elimination with Graph Convolutional Networks), a framework that combines feature selection and classification in a single pipeline. Our approach builds a graph from gene expression profiles, uses a Graph Convolutional Network to classify cancer versus normal samples, and applies Integrated Gradients to highlight the most informative genes. By recursively removing less relevant genes, the model converges to a compact set of biomarkers that are both interpretable and predictive. We evaluated RGE-GCN on synthetic data as well as real-world RNA-seq cohorts of lung, kidney, and cervical cancers. Across all datasets, the method consistently achieved higher accuracy and F1-scores than standard tools such as DESeq2, edgeR, and limma-voom. Importantly, the selected genes aligned with well-known cancer pathways including PI3K-AKT, MAPK, SUMOylation, and immune regulation. These results suggest that RGE-GCN shows promise as a generalizable approach for RNA-seq based early cancer detection and biomarker discovery (https://rce-gcn.streamlit.app/ ).</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>12 pages, 2 figures</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>